pseudomonas aeruginosa (schroeter) migula (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
99
Structured Review
ATCC
pseudomonas aeruginosa (schroeter) migula
Pseudomonas Aeruginosa (Schroeter) Migula, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 22825 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+aeruginosa/Pseudomonas+aeruginosa+(Schroeter)+Migula/custom%4027853%4042257380
Average 99 stars, based on 22825 article reviews
Pseudomonas Aeruginosa (Schroeter) Migula, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 22825 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+aeruginosa/Pseudomonas+aeruginosa+(Schroeter)+Migula/custom%4027853%4042257380
Average 99 stars, based on 22825 article reviews
pseudomonas aeruginosa (schroeter) migula - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Ex Vivo:Article Title: Discovery of BI-10: An Unexplored Broad-Spectrum Antimicrobial Benzimidazole Derivative Targeting Bacterial Membrane. Article Snippet: Antimicrobial resistance (AMR) has emerged as a global healthcare crisis, necessitating the discovery of potent antibacterial agents.. In the present investigation, we report the discovery, in vitro and ex vivo antibacterial efficacy studies, and mechanism of action of an unexplored benzimidazole derivative (BI-10), a promising broad-spectrum antibacterial agent with significant efficacy against Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA).. BI-10 demonstrated a minimum Inhibitory Concentration (MIC) of 2.4 μg/ml (6.25 μM) against these priority pathogens. Infection:Article Title: Discovery of BI-10: An Unexplored Broad-Spectrum Antimicrobial Benzimidazole Derivative Targeting Bacterial Membrane. Article Snippet: Antimicrobial resistance (AMR) has emerged as a global healthcare crisis, necessitating the discovery of potent antibacterial agents.. In the present investigation, we report the discovery, in vitro and ex vivo antibacterial efficacy studies, and mechanism of action of an unexplored benzimidazole derivative (BI-10), a promising broad-spectrum antibacterial agent with significant efficacy against Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA).. BI-10 demonstrated a minimum Inhibitory Concentration (MIC) of 2.4 μg/ml (6.25 μM) against these priority pathogens. Concentration Assay:Article Title: Devices and methods for delivering synergistic active agents to target sites Article Snippet: .. Minimum Inhibitory Concentration Determination for Antiseptics The minimal inhibitory concentration (MIC, the minimum inhibitory concentration required for 90% growth reduction) of ethyl lauroyl arginate hydrochloride was determined against S. aureus (ATCC 6538), Article Title: Dual-action antimicrobial peptide therapy: disrupting biofilm formation and targeting bacterial DNA for enhanced treatment of Pseudomonas aeruginosa endophthalmitis. Article Snippet: .. Bacterial strains and minimal inhibitory concentration Standard bacterial strains were stored in the laboratory: S. aureus (ATCC 43300 and ATCC 6538), Diffusion-based Assay:Article Title: An assessment of curcumin, curcumin spanlastics nanoparticles, and curcumin nanocrystals as possible drug delivery systems with antimicrobial, antioxidant, and antitumor activities Article Snippet: .. Preliminary screening of the antimicrobial action of the tested compounds (curcumin, spanlastics-free, curcumin nanocrystals, and curcumin spanlastic nanoparticles) against a panel of different microbial reference strains, including S. aureus (ATCC 25923), E. faecalis (ATCC 29212), E. coli (ATCC 25922), K. pneumoniae (ATCC 700603), |